Submission from Lallemand

Lallemand Health Solutions (part of Lallemand Group of companies, a global leader in the probiotic industry) specializes in the research, development, production, and marketing of bacteria and yeast based probiotic supplements for human applications. With a range of evidence-based probiotic solutions, it also offers specifically designed solutions to sustain growing infants’ gut microbiome with higher proportion of the gut friendly, Bifidobacteria. This solution encourages smooth and timely evolution of the gut microbiota, supporting key infant developmental stages and promotion of overall well-being.

The innovation.

Prenatis™: Nurturing life, from mom to baby.
Prenatis™ is Lallemand Health Solutions’ newest probiotic product – a combination of two proprietary strains known for their safety and efficacy: L. rhamnosus Rosell®-11 and B. bifidum HA-132. Prenatis™ potency was investigated in a large-scale, gold-standard clinical trial with rigorous measurements of several parameters in 180 healthy pregnant women during their third trimester. Follow-ups were conducted on mothers and their babies up to one year old.

The benefits.

Prenatis™: Maintain a healthy pregnancy and contributes to the establishment of healthy infant microbiome.
The study revealed positive outcomes in maintaining healthy pregnancy and contributed to the establishment of healthy infant microbiome.
Prenatis™ can be combined with other probiotic strains. It is available in multiple convenient formats, including powder in sachets or sticks, orodispersible powder, and capsules in blisters or bottles. This flexibility ensures ease of use for expectant mothers. Prenatis™ represents a significant leap in perinatal health, supporting both maternal and infants’ well-being whilst laying the foundation for a healthy infant microbiome.

Additional materials:

Visit our dedicated website to learn more